Literature DB >> 16534770

Progression of cerebral white matter lesions is not associated with development of depressive symptoms in elderly subjects at risk of cardiovascular disease: The PROSPER Study.

C E Versluis1, R C van der Mast, M A van Buchem, E L E M Bollen, G J Blauw, J A H Eekhof, N J A van der Wee, A J M de Craen.   

Abstract

BACKGROUND: Cerebral white matter hyperintensities on magnetic resonance imaging (MRI) scans have been associated with vascular disease and late-life depression, both in the general population and in psychiatric patients. Therefore, a cerebrovascular etiology for late-onset depression has been hypothesized. However, longitudinal studies on the causal role of white matter hyperintensities in the development of depressive symptoms in elderly adults are lacking.
OBJECTIVE: To investigate the relation between white matter hyperintensities and depressive symptoms in elderly subjects at risk of cardiovascular disease.
METHODS: In the Dutch sample of the PROSPER (PROspective Study of Pravastatine in the Elderly at Risk of cardiovascular disease) cohort, 527 non-demented elderly, all aged 70 years or older, received a cranial MRI scan and the 15-item Geriatric Depression Scale, at baseline and 33 months (SD 1.6) later.
RESULTS: Presence of white matter hyperintensities at baseline was not related to baseline depressive symptoms nor to the development of depressive symptoms during follow-up. Moreover, no association was found between progression of white matter lesion volume and progression of depressive symptoms.
CONCLUSION: This longitudinal study does not confirm the involvement of cerebrovascular disease expressed as MRI white matter hyperintensities in the development of depressive symptoms in elderly subjects. Copyright (c) 2006 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2006        PMID: 16534770     DOI: 10.1002/gps.1477

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  10 in total

1.  Organic bases of late-life depression: a critical update.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2013-01-25       Impact factor: 3.575

2.  Effects of age on white matter integrity and negative symptoms in schizophrenia.

Authors:  Kelly Rowe Bijanki; Brendan Hodis; Vincent A Magnotta; Eugene Zeien; Nancy C Andreasen
Journal:  Schizophr Res       Date:  2014-06-20       Impact factor: 4.939

3.  Cerebral Small Vessel Disease and Association With Higher Incidence of Depressive Symptoms in a General Elderly Population: The AGES-Reykjavik Study.

Authors:  Thomas T van Sloten; Sigurdur Sigurdsson; Mark A van Buchem; Caroline L Phillips; Palmi V Jonsson; Jie Ding; Miranda T Schram; Tamara B Harris; Vilmundur Gudnason; Lenore J Launer
Journal:  Am J Psychiatry       Date:  2015-03-03       Impact factor: 18.112

4.  Temporal lobe atrophy and white matter lesions are related to major depression over 5 years in the elderly.

Authors:  Pernille J Olesen; Deborah R Gustafson; Michela Simoni; Leonardo Pantoni; Svante Ostling; Xinxin Guo; Ingmar Skoog
Journal:  Neuropsychopharmacology       Date:  2010-09-29       Impact factor: 7.853

5.  Temporal relationships between depressive symptoms and white matter hyperintensities in older men and women.

Authors:  Vonetta M Dotson; Alan B Zonderman; Michael A Kraut; Susan M Resnick
Journal:  Int J Geriatr Psychiatry       Date:  2012-03-13       Impact factor: 3.485

Review 6.  Association of Microvascular Dysfunction With Late-Life Depression: A Systematic Review and Meta-analysis.

Authors:  Marnix J M van Agtmaal; Alfons J H M Houben; Frans Pouwer; Coen D A Stehouwer; Miranda T Schram
Journal:  JAMA Psychiatry       Date:  2017-07-01       Impact factor: 21.596

Review 7.  Bipolar and major depressive disorder: neuroimaging the developmental-degenerative divide.

Authors:  Jonathan Savitz; Wayne C Drevets
Journal:  Neurosci Biobehav Rev       Date:  2009-01-21       Impact factor: 8.989

8.  Antidepressant use is related to larger white matter lesion volume in patients with symptomatic atherosclerotic disease: the SMART-MR study.

Authors:  Anne M Grool; Yolanda van der Graaf; Koen L Vincken; Theo D Witkamp; Willem P Th M Mali; Mirjam I Geerlings
Journal:  J Neurol       Date:  2012-08-05       Impact factor: 4.849

9.  Aspirin for the prevention of cognitive decline in the elderly: rationale and design of a neuro-vascular imaging study (ENVIS-ion).

Authors:  Christopher M Reid; Elsdon Storey; Tien Y Wong; Robyn Woods; Andrew Tonkin; Jie Jin Wang; Anthony Kam; Andrew Janke; Rowan Essex; Walter P Abhayaratna; Marc M Budge
Journal:  BMC Neurol       Date:  2012-02-08       Impact factor: 2.474

10.  Association of white matter hyperintensities with migraine features and prognosis.

Authors:  Hui Xie; Qiang Zhang; Kang Huo; Rui Liu; Zhi-Jie Jian; Yi-Tong Bian; Guo-Liang Li; Dan Zhu; Li-Hui Zhang; Jian Yang; Guo-Gang Luo
Journal:  BMC Neurol       Date:  2018-07-02       Impact factor: 2.474

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.